CYTX-INVESTOR.COM

Investing in the most promising platform of regenerative medicine

Welcome to Cytx-Investor.com

  • Describing THE future Platform of Regenerative Medicine
    Describing THE future Platform of Regenerative Medicine The page where you can find all relevant information about Cytori Therapeutics Inc, listed on Nasdaq- Symbol-CYTX. You can learn about its history, the people at Cytori and its disruptive technology. But primarily you can find here information on its broad therapeutic application platform by developing therapies with adipose derived regenerative cells (ADRC´s) against a whole range of presently unmet medical needs. This therapeutic application platform provides Cytori with a gigantic market potential, which is presently unfolding for anybody, that is willing to see it. Without a doubt the technology of Cytori will treat millions of patients in the nearby future...
    3 comments Read more...

Latest Editor´s Note

  • Global Healthcare and Cytori
    Global Healthcare and Cytori On August 8 2013 Cytori reported its results on Q2 and held its usual Conference Call to discuss business developments. Some folks stamped it as being the worst call made since 7 years and the ensuing market reaction the next day more or less confirmed that view. I would not deny that or try to argue otherwise. It probably was the worst call for a very long time, but on the other hand it provided also a lot of clarity, which surely was difficult to discover, for which reason this article. Lets start with this- the most important statement: "We're creating an autologous point-of-care system. We're not manipulating cells. The business model really works. It's affordable. These aren't $xxx,000 therapies. They're a few thousand dollars…
    2 comments Read more...

Latest Platform Tech Article

  • Orphan disease- cutaneous systemic scleroderma
    Orphan disease- cutaneous systemic scleroderma Scleroderma is a connective tissue disease that involves changes in the skin, blood vessels, muscles, and internal organs. It is a type of auto immune disorder, a condition that occurs when the immune system mistakenly attacks and destroys healthy body tissue. Causes, incidence, and risk factors The cause of scleroderma is unknown. People with this condition have a buildup of a substance called collagen in the skin and other organs. This buildup leads to the symptoms of the disease. The disease usually affects people 30 to 50 years old. Women get scleroderma more often than men do. Some people with scleroderma…
    1 comment Read more...
About Caplan, Cardiac and The One That Got Away
  If there is one thing that MDs and scientists who briefly experiment with fat cells agree upon with their colleagues who devote most of their lives studying these cells than it would be - yes-...
Continue Reading...
Abe regenerative law passes upper house in japan
On November 20 the following short article appeared in the Japan Times:  The Upper House passed a bill Wednesday aimed at ensuring the safety of regenerative medicine and another to revise the p...
Continue Reading...
Cytori Cell Therapy for the Millions?
Mystery Chinese Investor closes deal with Mystery Company Cytori   Cytori investors were pleasantly surprised shortly before the third quarter call with an announcement that Lorem Vascular- Hea...
Continue Reading...
Half a can of coke..
{eblogads right}of fat tissue extracted from the subcuteneous part of the belly, is the standard introduction by all presenters of Cytori managers at Investor conferences over the past eight years, wh...
Continue Reading...
About biomaterials and "bone" experts
In the "Editor´s notes" of this Cytx-Investor.com page, I raised the question a few days back, whether the manufacturing partners of Cytori, Olympus Corp are visionaries.{eblogads left}The answer to t...
Open Letter to Cytori Chairman Mr. Lloyd Dean
Lloyd,   No doubt you are being inundated by emails from angry stockholders. As you may remember I am  (text deleted) and investing in the stock market is an active hobby of mine. I have m...
BioWorlds: Cytori Fattens Coffers
I found this article in my mailbox yesterday, which appeared on the respected BioWorld Daily Biopharmaceutical News Site, written by Mr. R. Osborne. I think it has some positive statements, which othe...
The Backdoor pathway to the Regenerative Markets
This week I was watching a recording of an analysts panel on the Cell Therapy Industry, which included Jason Kolbert, Steve Brozak and Jason Napodano (the video is also posted in the Raccoons Lodge). ...

Selected Editor Notes

Written by Fas Kuiters
  • 100% Hardcore-the power of the gimish
    100% Hardcore-the power of the gimish This article is 100% hardcore- rather technical, so really for the happy few with ambitions to understand all that jazz. On the other hand, the introduction and its message is provided in the first half, which is really very simple- i.e. fact is, that Cytori management has regarded its shareholders as "dumbo´s" for…
    Written on Monday, 30 April 2012 15:52 Read more...
  • Are the Olympus folks "visionary"?
    Are the Olympus folks "visionary"? Sometime in the early goings- 2007 or there abouts, when I still had my quarterly calls with CFO Mark Saad (which I later stopped since no value was added after an initial learning curve), I asked him the question whether he thought a partner deal in the bone regeneration field…
    Written on Wednesday, 30 May 2012 15:16 Read more...
  • Major Milestones achieved in the development of the Cytori application platform
    Major Milestones achieved in the development of the Cytori application platform ...and hardly anybody realizes the above stated fact. The shareholders letter from Cytori, which was released on August 8 together with the Q2 numbers, contained some amazing lines, which apparently very few people have read sofar. These were the following- we are pleased to add new CE Mark indications-for-use based…
    Written on Tuesday, 14 August 2012 11:57 Read more...
  • Biding our time
    Biding our time Today- August 23 2012- a short while after the 2td quarter call and annual meeting webcast, investors, who a few weeks back were raging from anger, because of the non-execution of the promised pending partner deal in April, were converted back again into hopeful and confident investors, knowing that their…
    Written on Tuesday, 21 August 2012 14:26 Read more...
  • The Valley of Death- and Elephant Hunters theory re-visited
    The Valley of Death- and Elephant Hunters theory re-visited In January 2011 an excellent article appeared on Seeking Alpha written by John Petersen on the above theory- link here which I found very interesting and I believe applies to large degree also to Cytori. Key difference though is that CYTX innovation in addition to development also has to jump regulatory…
    Written on Wednesday, 05 September 2012 15:00 Read more...
  • The Biological Goldmine Confirmed
    The Biological Goldmine Confirmed On January 8 2013 our beloved CEO Chris Calhoun made his "usual (?)" presentation at the Biotech Showcase conference in San Francisco. "Usual" since one could read afterwards from expert investors, that they did not hear anything new or special after listening to the webcast of the conference. To me…
    Written on Wednesday, 09 January 2013 10:58 Read more...
  • Mr.Dean- show me the money!
    Mr.Dean- show me the money! Dear Lloyd, I just checked my records-besides the usual mess, I could only find a statement from my bank dated somewhere in 2002, that my last purchase of MacroPore stock on the German exchange was made on September 20, 2001. The other purchases of my holdings at the time of…
    Written on Friday, 08 February 2013 20:09 Read more...

Editor´s favorite articles

Written by Fas Kuiters

These articles are really my favorites- the first one brought me to the science and in respects of the other articles, I am proud to be the author of their content, although it does not bring me a dime.

  • Visions of the Future
    Visions of the Future In the earlier editions of CYTX-Investor.com I started this section with the visions of Prof. David Williams on regenerative medicine. Not that the visions of Prof. Williams will resemble exactly the past-, present- or future development of Cytori technology- could be , doesnt have to be though. His visions DO however, provide…
    Written on Tuesday, 31 January 2012 21:00 Read more...
  • Partner- Astellas Pharma Inc
    Partner- Astellas Pharma Inc Actually Astellas is of course a little more than just a candidate, since on December 7, 2010 they took an equity participation in Cytori, with the first right to negotiate a deal on liver regeneration. Cytori explained this in a note as follows: Such a partnership would likely revolve around…
    Written on Monday, 09 April 2012 21:13 Read more...
  • Mechanisms of Action of ADRCs
    Mechanisms of Action of ADRCs In the Wall Street press one always reads, when the theme "stem cells" comes up, what the difference in adult- and embryonic cell differentiation potential is and what these magic things all can do, or what they cant do. Words like pluripotency, multipotency and sometimes even the word progenitor cell…
    Written on Friday, 03 February 2012 19:48 Read more...
  • The versatility of Celution
    The versatility of Celution There seem to be several misconceptions or maybe just different opinions about the ability for Cytori to protect the IP, which went into the designing- and engineering of the Celution range of products. Thereto different opinions about the technical superiority of the same system. I do not think the following…
    Written on Saturday, 04 February 2012 19:34 Read more...

 

Cytori- The Company- all articles

Written by Fas Kuiters
  • Introduction to Cytori Therapeutics
    Introduction to Cytori Therapeutics Cytori´s Company slogan is: "Restoring Lives" - thereto its logo still displays the former slogan: "Where infinite possibilities meet" Both logo and slogan are really to my liking and I feel…
    Written on Sunday, 01 January 2012 18:57 Read 2619 times Read more...
  • Cytori´s history- untill 2005
    Cytori´s history- untill 2005 Article- History untill 2005.   Cytori became Cytori on July 11 2005 when the name change from MacroPore Biosurgery became official. Before that date, MacroPore obviously had some history too.…
    Written on Monday, 09 January 2012 20:03 Read 2312 times Read more...
  • Reflections on 11 years CYTX listing
    Reflections on 11 years CYTX listing MacroPore was from an investors viewpoint- kind of "the dark side" of Cytori- not only because of the failed Medtronic partnership on bio-resorbable implants, but also because of excessive option-plans and…
    Written on Thursday, 12 January 2012 11:58 Read 2396 times Read more...
  • The managers at Cytori
    The managers at Cytori   The management Team Of Cytori. The team is led by one of its Co-founders - Christopher J. Calhoun Chief Executive Officer   Christopher J. Calhoun is a co-founder of…
    Written on Sunday, 29 January 2012 18:58 Read 2383 times Read more...
  • Cytori´s Board of Directors
    Cytori´s Board of Directors First- some historical development- Untill 2007 Cytori´s Board of Directors was more of an "good ol boys" club, although by SEC rules considered " pre-dominantly independent". The father-in-law of CEO Calhoun…
    Written on Monday, 30 January 2012 21:22 Read 18112 times Read more...
  • Location & Mission
    Location & Mission To conclude the first round of articles on Cytori- The Company, just an overview of the location from which the world of regenerative medicine will be conquered and what these folks who…
    Written on Monday, 30 January 2012 23:17 Read 1906 times Read more...
  • Partner Olympus
    Partner Olympus Partner Olympus, as a Company, has major issues to resolve after the accounting cover-up scandal emerged. Dont want to comment that here, but you can read all about Woodford, Kikukawa…
    Written on Wednesday, 29 February 2012 16:45 Read 2207 times Read more...
  • Partner Roche
    Partner Roche Second partner I would like to present here is Hoffmann La Roche- short -Roche. In the same conference call early 2009 when Calhoun talked about his partners, he described the proprietary enzyme…
    Written on Saturday, 03 March 2012 00:13 Read 2274 times Read more...
  • Partner- Astellas Pharma Inc
    Partner- Astellas Pharma Inc Actually Astellas is of course a little more than just a candidate, since on December 7, 2010 they took an equity participation in Cytori, with the first right to negotiate…
    Written on Monday, 09 April 2012 21:13 Read 2081 times Read more...

Latest CYTX PR

Follow my journey

Follow me

Fas Tweetdeck Timeline

Raccoon Lodge Latest

Latest Comments

Thanks Fas as always appreciate your updates and insight. I wish that Cytori mangement was as interested in providing shareholders with perspective as...
Hi Fas...I did get the emailed copy but since you posted it here for comment... I think the diabetic foot ulcer study is very exciting and should prod...
For all who did not receive my newsletter from December 16- you can view it by clickiing the link below this comment
Agreed, Fas and as shareholders we are left completely in the dark. I saw you post indicating that CYTX is being dropped from the index which accounts...
Hi Michael- yes- I presume everyone is frustrated, I do not think I am leading the pack there, but it would be silly after all the words that has been...
Hi Allen-
Sure I remember you. Thank you for your patience and trust. I am convinced it will be worth it.
In respect of your issues- sure I c...

Fat cell Tidbits

 

Sponsors of the Site

 

Video of the year 2013

Click on link below image for the video pop-up

arnold-i-caplan

Arnold Caplan on Fatcells